Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules

被引:91
|
作者
Ito, N
Wernstedt, C
Engström, U
Claesson-Welsh, L
机构
[1] Uppsala Univ, Ctr Biomed, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden
[2] Biomed Ctr, Ludwig Inst Canc Res, Uppsala Branch, S-75124 Uppsala, Sweden
关键词
D O I
10.1074/jbc.273.36.23410
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Receptor tyrosine phosphorylation is crucial for sig nal transduction by creating high affinity binding sites for Src homology 2 domain-containing molecules. By expressing the intracellular domain of Flt-1/vascular endothelial growth factor receptor-1 in the baculosystem, we identified two major tyrosine phosphorylation sites at Tyr-1213 and Tyr-1242 and two minor tyrosine phosphorylation sites at Tyr-1327 and Tyr-1333 in this receptor. This pattern of phosphorylation of Flt-1 was also detected in vascular endothelial growth factor-stimulated cells expressing intact Flt-1. In vitro protein binding studies using synthetic peptides and immunoblotting showed that phospholipase C-gamma binds to both Y(p)1213 and Y(p)1333, whereas Grb2 and SHP2-containing tyrosine protein phosphatase (SHP-2) bind to Y(p)1213, and Nck and Crk bind to Y(p)1333 in a phosphotyrosine-dependent manner. In addition, unidentified proteins with molecular masses around 74 and 27 kDa bound to Y(p)1213 and another of 75 kDa bound to Y(p)1333 in a phosphotyrosine-dependent manner. SHP-2, phospholipase C-gamma, and Grb2 could also be shown to bind to the intact Flt-1 intracellular domain. These results indicate that a spectrum of already known as well as novel phosphotyrosine-binding molecules are involved in signal transduction by Flt-1.
引用
收藏
页码:23410 / 23418
页数:9
相关论文
共 50 条
  • [21] Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1
    Tsui, Florence W. L.
    Martin, Alberto
    Wang, John
    Tsui, Hing Wo
    IMMUNOLOGIC RESEARCH, 2006, 35 (1-2) : 127 - 136
  • [22] Investigations into the regulation and function of the SH2 domain-containing protein-tyrosine phosphatase, SHP-1
    Florence W. L. Tsui
    Alberto Martin
    John Wang
    Hing Wo Tsui
    Immunologic Research, 2006, 35 : 127 - 136
  • [23] SHIP2 (SH2 Domain-containing Inositol Phosphatase 2) SH2 Domain Negatively Controls SHIP2 Monoubiquitination in Response to Epidermal Growth Factor
    De Schutter, Julie
    Guillabert, Aude
    Imbault, Virginie
    Degraef, Chantal
    Erneux, Christophe
    Communi, David
    Pirson, Isabelle
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (52) : 36062 - 36076
  • [24] Role of Tyrosine Phosphatase Inhibitors in Cancer Treatment with Emphasis on SH2 Domain-Containing Tyrosine Phosphatases (SHPs)
    Irandoust, Mahban
    van den Berg, Timo K.
    Kaspers, Gertjan J. L.
    Cloos, Jacqueline
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (02) : 212 - 220
  • [25] Vascular endothelial cell growth factor-driven endothelial tube formation is mediated by vascular endothelial cell growth factor receptor-2, a kinase insert domain-containing receptor
    Yang, SY
    Xin, XH
    Zlot, C
    Ingle, G
    Fuh, G
    Li, B
    Moffat, B
    de Vos, AM
    Gerritsen, ME
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) : 1934 - 1940
  • [26] Identification of SH2 domain-containing proteins and motifs prediction by a deep learning method
    Wu, Duanzhi
    Fang, Xin
    Luan, Kai
    Xu, Qijin
    Lin, Shiqi
    Sun, Shiying
    Yang, Jiaying
    Dong, Bingying
    Manavalan, Balachandran
    Liao, Zhijun
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 162
  • [27] Membrane-targeting of signalling molecules by SH2/SH3 domain-containing adaptor proteins
    Buday, L
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES, 1999, 1422 (02): : 187 - 204
  • [28] Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization
    Landsman, T
    Waxman, DJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (45) : 37471 - 37480
  • [29] Fibroblast growth factor receptor 1 mediates chemotaxis independently of direct SH2 domain protein binding
    Landgren, E
    Klint, P
    Yokote, K
    Claesson-Welsh, L
    ONCOGENE, 1998, 17 (03) : 283 - 291
  • [30] The binding of peptide motifs containing modified tyrosine residues to the SH2 domain of FYN
    Amaning, K
    Jones, DJL
    Lamb, JH
    Lord, GA
    Roberts, GCK
    Shuker, DEG
    TOXICOLOGY, 2001, 164 (1-3) : 198 - 198